AAAAAA

   
Results: 1-10 |
Results: 10
EVALUATION OF STAGING LYMPHADENECTOMY IN PROSTATE-CANCER
Authors: ELGALLEY RES KEANE TE PETROS JA SANDERS WH CLARKE HS COTSONIS GA GRAHAM SD
Citation: Res. Elgalley et al., EVALUATION OF STAGING LYMPHADENECTOMY IN PROSTATE-CANCER, Urology, 52(4), 1998, pp. 663-667
CAMPTOTHECIN ANALOGUES CISPLATIN - AN EFFECTIVE TREATMENT OF ADVANCEDBLADDER-CANCER IN A PRECLINICAL IN-VIVO MODEL SYSTEM/
Authors: KEANE TE ELGALLEY RES SUN C PETROS JA DILLAHEY D GOMAA A GRAHAM SD MCGUIRE WP
Citation: Te. Keane et al., CAMPTOTHECIN ANALOGUES CISPLATIN - AN EFFECTIVE TREATMENT OF ADVANCEDBLADDER-CANCER IN A PRECLINICAL IN-VIVO MODEL SYSTEM/, The Journal of urology, 160(1), 1998, pp. 252-256
IRENOTECAN (CPT-11) IN ADVANCED RENAL-CELL CARCINOMA - RESULTS OF A MULTI DOSE STUDY DEFINING THE MINIMAL EFFECTIVE DOSE USING A MODEL OF ADVANCED RENAL-CELL CARCINOMA (RCC)
Authors: KEANE TE HARRIS WB SUN C KARR J PETROS JA GRAHAM SD
Citation: Te. Keane et al., IRENOTECAN (CPT-11) IN ADVANCED RENAL-CELL CARCINOMA - RESULTS OF A MULTI DOSE STUDY DEFINING THE MINIMAL EFFECTIVE DOSE USING A MODEL OF ADVANCED RENAL-CELL CARCINOMA (RCC), The Journal of urology, 159(5), 1998, pp. 751-751
2 CASES OF VASCULITIS OF THE URINARY-BLADDER - DIAGNOSTIC AND PATHOGENETIC CONSIDERATIONS
Authors: FISCHER AH WALLACE VL KEANE TE CLARKE HS
Citation: Ah. Fischer et al., 2 CASES OF VASCULITIS OF THE URINARY-BLADDER - DIAGNOSTIC AND PATHOGENETIC CONSIDERATIONS, Archives of pathology and laboratory medicine, 122(10), 1998, pp. 903-906
NORMAL RANGE PROSTATE-SPECIFIC ANTIGEN VERSUS AGE-SPECIFIC PROSTATE-SPECIFIC ANTIGEN IN SCREENING PROSTATE ADENOCARCINOMA
Authors: ELGALLEY RES PETROS JA SANDERS WH KEANE TE GALLOWAY NTM COONER WH GRAHAM SD
Citation: Res. Elgalley et al., NORMAL RANGE PROSTATE-SPECIFIC ANTIGEN VERSUS AGE-SPECIFIC PROSTATE-SPECIFIC ANTIGEN IN SCREENING PROSTATE ADENOCARCINOMA, Urology, 46(2), 1995, pp. 200-204
INTRAVESICAL SURAMIN IN THE PREVENTION OF TRANSITIONAL-CELL CARCINOMA
Authors: GRAHAM SD NAPALKOV P OLADELE A KEANE TE PETROS JA CLARKE HS KASSABIAN VS DILLEHAY DL
Citation: Sd. Graham et al., INTRAVESICAL SURAMIN IN THE PREVENTION OF TRANSITIONAL-CELL CARCINOMA, Urology, 45(1), 1995, pp. 59-63
PERIOPERATIVE HORMONAL-THERAPY IN LOCALLY ADVANCED ADENOCARCINOMA OF THE PROSTATE
Authors: GRAHAM SD KEANE TE PETROS JA SANDERS WH
Citation: Sd. Graham et al., PERIOPERATIVE HORMONAL-THERAPY IN LOCALLY ADVANCED ADENOCARCINOMA OF THE PROSTATE, Cancer, 75(7), 1995, pp. 1969-1971
IMPOTENCE FOLLOWING PELVIC FRACTURE URETHRAL INJURY - INCIDENCE, ETIOLOGY AND MANAGEMENT
Authors: MARK SD KEANE TE VANDEMARK RM WEBSTER GD
Citation: Sd. Mark et al., IMPOTENCE FOLLOWING PELVIC FRACTURE URETHRAL INJURY - INCIDENCE, ETIOLOGY AND MANAGEMENT, British Journal of Urology, 75(1), 1995, pp. 62-64
METHOXYPSORALEN PHOTOTHERAPY OF TRANSITIONAL-CELL CARCINOMA
Authors: KEANE TE PETROS JA VELIMIROVICH B YUE KT GRAHAM SD
Citation: Te. Keane et al., METHOXYPSORALEN PHOTOTHERAPY OF TRANSITIONAL-CELL CARCINOMA, Urology, 44(6), 1994, pp. 842-846
COMBINATION VERSUS SINGLE-AGENT THERAPY IN EFFECTING COMPLETE THERAPEUTIC RESPONSE IN HUMAN BLADDER-CANCER - ANALYSIS OF CISPLATIN AND OR 5-FLUOROURACIL IN AN IN-VIVO SURVIVAL MODEL
Authors: KEANE TE GINGRICH JR ROSNER G WEBB KS POULTON SH WALTHER PJ
Citation: Te. Keane et al., COMBINATION VERSUS SINGLE-AGENT THERAPY IN EFFECTING COMPLETE THERAPEUTIC RESPONSE IN HUMAN BLADDER-CANCER - ANALYSIS OF CISPLATIN AND OR 5-FLUOROURACIL IN AN IN-VIVO SURVIVAL MODEL, Cancer research, 54(2), 1994, pp. 475-481
Risultati: 1-10 |